COMMUNIQUÉS West-GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
19/03/2026 -
electroCore Announces Full Year 2025 Financial Results and Organizational Changes
19/03/2026 -
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
19/03/2026 -
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
19/03/2026 -
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
19/03/2026 -
Trading in GN Store Nord shares by board members, executives and associated persons
19/03/2026 -
Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026
19/03/2026 -
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
19/03/2026 -
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
19/03/2026 -
Teva Releases Q1 2026 Aide Memoire
19/03/2026 -
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
19/03/2026 -
SK pharmteco réaffirme sa stratégie à trois unités d’activité et renforce son pôle mondial de thérapie génique grâce à un engagement de financement
19/03/2026 -
NMDP Celebrates Bipartisan Senate Introduction of Life-saving Blood Stem Cell Therapeutic and Research Reauthorization Act
19/03/2026 -
The Endothelial Glycocalyx Explained: How It Helps Regulate Vascular Function
19/03/2026 -
Fangzhou Reports Robust 2025 Financial Results, Boosted by AI Chronic Care Strategy
19/03/2026 -
Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
19/03/2026 -
OKYO Pharma Announces Chairman and Founder Acquires Shares
19/03/2026 -
New partnership to fast-track Canadian health technology from innovation to patient care
19/03/2026 -
Backpage Sex Trafficking Survivors Break Silence, Demand Investigation of Uncharged Enablers as Compensation Deadline Approaches
19/03/2026
Pages